Dr Boreham's Crucible: Paradigm Biopharmaceuticals
Tim Boreham highlights the success of Paradigm Biopharmaceuticals' joint pain drug ahead of a capital raising
Source: fnarena.com
Stay updated with breaking news from Amos Meltzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tim Boreham highlights the success of Paradigm Biopharmaceuticals' joint pain drug ahead of a capital raising
“The achievements of FY21 are important in our journey as a company and help set a strong foundation for Paradigm to grow,” says interim chair and CEO.